再生医学
医学
重症监护医学
肾脏疾病
组织工程
分离(微生物学)
生物医学技术
风险分析(工程)
生物相容性材料
疾病
细胞疗法
生物医学工程
免疫系统
计算机科学
生物反应器
人工肾
透析
作者
Ziqi Zhang,Zehao Zhang,Tingting Zhang,Yaqi Wang,Yu Zhao,Yixue Zhang,Xiaolan Chen,Xiayin Li,Ming Bai
摘要
End-stage kidney disease (ESKD) demands novel treatments capable of simulating the physiological functions of native kidneys. The bioartificial kidney (BAK), combining a glomerular biomimetic filter and a cell-based bioreactor to restore tubular functions, is a promising therapeutic option that is still under preclinical development. This article reviews the technological evolution of BAK, summarizes the latest progress in membrane materials, cell resources and bioreactor construction, and elaborates on key supporting technologies such as kidney-on-a-chip systems, decellularization-recellularization and device miniaturization. Although considerable achievements have been made, critical hurdles including poor biocompatibility, unstable cell activity, immune isolation defects and insufficient vascularization still hinder its clinical application. Future development depends on interdisciplinary collaboration between precision medicine and smart bioengineering, to ultimately promote the clinical translation of BAK for ESKD treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI